UnknownNot Applicable

Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion

Egypt200 participantsStarted 2020-09-01

Plain-language summary

To compare the effect of vaginal dinoprostone versus vaginal misoprostol and Isonicotinic Acid Hydrazide administered before the copper intrauterine device(IUD) insertion in reducing IUD inertion pain and the difficulty in inserting the IUD in nulliparous women.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * nulliparous women requesting copper IUD insertion Exclusion Criteria: * pregnancy, * Parous women, * contraindications or allergy to dinoprostone or misoprostol,contraindication to IUD insertion, * untreated active cervicitis or vaginitis, * undiagnosed abnormal uterine bleeding

What they're measuring

The difference in visual analog scale pain scores during intrauterine device insertion

Timeframe: 10 minuts

Trial details

NCT IDNCT04505943

SponsorAswan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-07-30

Contact for this trial

hany f Sallam, md

+20102435461 hany.farouk@aswu.edu.eg

View on ClinicalTrials.gov More IUCD Complication trials